The Ali Model demonstrated that age and use of diabetes medication best discriminate PDAC-associated diabetes in a study conducted exclusively in women, with some predictive effects of beta-blockers, lipid-modifying agents, and acid disorder drugs ( Figure 4B ) ( Figure 4B ) (98), while the XGBoost model uses weight loss, and rapid destabilization of glucose homeostasis as discriminating risk factors for PDAC-associated diabetes ( Figure 4B ) ( Potential biomarkers and identifiers of new-onset diabetes to distinguish PDAC-associated diabetes and T2D Apart from clinical markers of T1D and clinical evidence of PDAC-associated diabetes that distinguish from T2D within NOD populations, there is a need to establish clinically relevant and reliable non-invasive blood biomarkers for the differentiation of diabetes and further knowledge in independent fields of T2D and PDAC
Bergman, R
However, some drugs can induce autophagic cell death in drug-resistant cancer cells (227)
de Heer J, Rasmussen C, Coy DH, Holst JJ
Chiu W-Y, Shih S-R, Tseng C-H
Tirzepatide/L-Carnitine belongs to a group of drugs called glucose-dependent insulinotropic polypeptide ( GIP ) and glucagon-like peptide-1 ( GLP-1 ) receptor agonists